Respan Dataset Explorer

How do anticholinecterase drugs influence on the action of acetylcholine?

Question 16Select one or more:

a.
Potentiate


b.
Protract


c.
Suppress


d.
Make it shorter

Anticholinesterase drugs inhibit the enzyme acetylcholinesterase, which breaks down acetylcholine in the synaptic cleft. By preventing the breakdown of acetylcholine, these drugs effectively increase the availability and action of acetylcholine at synapses. Here’s how the options relate to the action of acetylcholine:

- **a. Potentiate**: **True**. Anticholinesterase drugs potentiate the action of acetylcholine by increasing its concentration and duration of action at receptor sites.

- **b. Protract**: **True**. They protract (extend) the effects of acetylcholine by preventing its breakdown.

- **c. Suppress**: **False**. Anticholinesterase drugs do not suppress the action of acetylcholine; rather, they enhance it.

- **d. Make it shorter**: **False**. They do not make the action of acetylcholine shorter; they prolong it by inhibiting its breakdown.

Based on this reasoning, the correct answers are: **a and b.**

Indications for the anticholinesterase drugs:

Question 17Select one or more:

a.
Intestinal atony


b.
Asthma


c.
Atony of urinary bladder


d.
Glaucoma


e.
Renal colic


f.
Myasthenia

Anticholinesterase drugs are used to increase the levels of acetylcholine in the body by inhibiting the enzyme acetylcholinesterase. These drugs have several medical indications. Here are the relevant options for their use:

1. **a. Intestinal atony**: **True**. Anticholinesterase drugs can stimulate peristalsis and increase intestinal motility, making them useful in treating intestinal atony.

2. **b. Asthma**: **False**. Anticholinesterase drugs may not be indicated for asthma as they can cause bronchoconstriction instead of bronchodilation.

3. **c. Atony of urinary bladder**: **True**. These drugs can enhance bladder contractions and are used in cases of urinary retention due to bladder atony.

4. **d. Glaucoma**: **True**. Anticholinesterase drugs can decrease intraocular pressure by facilitating the drainage of aqueous humor, which is helpful in managing glaucoma.

5. **e. Renal colic**: **False**. Anticholinesterase drugs are not typically indicated for renal colic; other treatments for pain and spasms are preferred.

6. **f. Myasthenia gravis**: **True**. Anticholinesterase drugs are used as a primary treatment for myasthenia gravis to improve neuromuscular transmission and muscle strength.

Based on this analysis, the correct indications for anticholinesterase drugs are: **a, c, d, and f.**

Irreversible cholinesterase inhibitors are:

Question 18Select one or more:

a.
Organophosphorous compounds


b.
Neostigmine


c.
Armin


d.
Pyridostigmine bromide


e.
Donepezil

Irreversible cholinesterase inhibitors are substances that permanently inactivate the enzyme acetylcholinesterase, leading to prolonged effects of acetylcholine. The following options pertain to cholinesterase inhibitors:

1. **a. Organophosphorous compounds**: **True**. These are a class of irreversible cholinesterase inhibitors commonly used in pesticides and nerve agents.

2. **b. Neostigmine**: **False**. Neostigmine is a reversible cholinesterase inhibitor, not an irreversible one.

3. **c. Armin**: **True**. Armin (also known as "Azinphosmethyl") is an organophosphate compound and is therefore an irreversible cholinesterase inhibitor.

4. **d. Pyridostigmine bromide**: **False**. Pyridostigmine is also a reversible cholinesterase inhibitor.

5. **e. Donepezil**: **False**. Donepezil is a reversible inhibitor specifically used for the treatment of Alzheimer’s disease.

Based on this information, the correct answers for irreversible cholinesterase inhibitors are: **a and c.**

Localization of M-cholinergic receptors:

Question 19Select one or more:

a.
Cells of effector organs near the end of postganglionic cholinergic fiber


b.
Skeletal muscles


c.
Neurons of the spinal cord


d.
Carotid sinus


e.
Neurons of parasympathetic ganglions


f.
Chromaffin cells of adrenal medulla


g.
Neurons of sympathetic ganglions

M-cholinergic receptors (muscarinic receptors) are a type of acetylcholine receptor that are primarily found in various tissues that respond to parasympathetic nervous system stimulation. Here’s how the options relate to the localization of M-cholinergic receptors:

1. **a. Cells of effector organs near the end of postganglionic cholinergic fiber**: **True.** M-cholinergic receptors are located on the effector organs innervated by postganglionic parasympathetic fibers.

2. **b. Skeletal muscles**: **False.** Skeletal muscles contain nicotinic acetylcholine receptors, not muscarinic receptors.

3. **c. Neurons of the spinal cord**: **False.** While there may be some muscarinic receptors in the central nervous system, they are not primarily localized in spinal cord neurons.

4. **d. Carotid sinus**: **True.** M-cholinergic receptors can be found in various autonomic structures, including the carotid sinus, which helps in regulating blood pressure.

5. **e. Neurons of parasympathetic ganglions**: **False.** The neurons in parasympathetic ganglia primarily have nicotinic receptors. Muscarinic receptors are found on the postsynaptic targets.

6. **f. Chromaffin cells of adrenal medulla**: **False.** Chromaffin cells primarily respond to sympathetic stimulation (via catecholamines) and do not primarily express muscarinic receptors.

7. **g. Neurons of sympathetic ganglions**: **False.** Sympathetic ganglia primarily use nicotinic receptors for acetylcholine transmission.

Based on the above evaluations, the correct answers for the localization of M-cholinergic receptors are: **a and d.**

Localization of N-cholinoreceptors:

Question 20Select one or more:

a.
Chromaffin tissue of adrenal glands


b.
Sino-carotid zone


c.
Endings of efferent nerve


d.
Postganglionic endings of parasympathetic nerves


e.
Autonomic ganglions

N-cholinergic receptors (nicotinic receptors) are a type of acetylcholine receptor that is primarily found in specific locations throughout the nervous system and the autonomic nervous system. Here's how the options relate to the localization of N-cholinergic receptors:

1. **a. Chromaffin tissue of adrenal glands**: **True.** Nicotinic receptors are present on chromaffin cells in the adrenal medulla, where they respond to acetylcholine released from sympathetic preganglionic neurons.

2. **b. Sino-carotid zone**: **False.** The sino-carotid zone, which includes baroreceptors, primarily uses muscarinic receptors and not nicotinic receptors.

3. **c. Endings of efferent nerve**: **False.** While nicotinic receptors are located in various parts of the nervous system, they are not typically found at the endings of efferent (motor) nerves, where muscarinic receptors are predominant.

4. **d. Postganglionic endings of parasympathetic nerves**: **False.** The postganglionic endings of parasympathetic nerves utilize muscarinic receptors; nicotinic receptors are located earlier in the synaptic pathway.

5. **e. Autonomic ganglions**: **True.** Nicotinic receptors are located on the postganglionic neurons in both the sympathetic and parasympathetic autonomic ganglia.

Based on this analysis, the correct answers for the localization of N-cholinergic receptors are: **a and e.**

M-cholinergic receptor is:

Question 21Select one or more:

a.
Ligand-gated channel


b.
Transmembrane protein


c.
G-protein-coupled receptor


d.
Nuclear receptor

M-cholinergic receptors (muscarinic receptors) are a subclass of acetylcholine receptors that mediate various physiological responses in the body. Here’s how the options relate to the characteristics of M-cholinergic receptors:

1. **a. Ligand-gated channel**: **False.** M-cholinergic receptors are not ligand-gated ion channels; they are G-protein-coupled receptors.

2. **b. Transmembrane protein**: **True.** M-cholinergic receptors are transmembrane proteins that span the cell membrane.

3. **c. G-protein-coupled receptor**: **True.** M-cholinergic receptors are a type of G-protein-coupled receptor, which means they exert their effects through intracellular signaling pathways activated by G-proteins upon binding of acetylcholine.

4. **d. Nuclear receptor**: **False.** M-cholinergic receptors are not nuclear receptors; nuclear receptors are involved in regulating gene expression in response to hormone binding.

Based on this analysis, the correct answers regarding the characteristics of M-cholinergic receptors are: **b and c.**

N-cholinergic receptor is:

Question 22Select one or more:

a.
G-protein-coupled receptor


b.
Ligand-gated channel


c.
Transmembrane protein


d.
Nuclear receptor

N-cholinergic receptors (nicotinic receptors) have specific characteristics that distinguish them from other types of receptors. Here’s how the options relate to N-cholinergic receptors:

1. **a. G-protein-coupled receptor**: **False.** N-cholinergic receptors are not G-protein-coupled receptors; they function differently.

2. **b. Ligand-gated channel**: **True.** N-cholinergic receptors are ligand-gated ion channels that open in response to the binding of acetylcholine, allowing ions (such as sodium) to flow into the cell.

3. **c. Transmembrane protein**: **True.** N-cholinergic receptors are transmembrane proteins that span the cell membrane.

4. **d. Nuclear receptor**: **False.** N-cholinergic receptors are not nuclear receptors; nuclear receptors function in the cell nucleus and are involved in gene regulation.

Based on this analysis, the correct answers regarding the characteristics of N-cholinergic receptors are: **b and c.**

Select Anticholinesterase drugs:

Question 23Select one or more:

a.
Pyridostigmine bromide


b.
Edrophonium chloride


c.
Carbachol


d.
Donepezil


e.
Aceclidine


f.
Armin


g.
Neostigmine

Anticholinesterase drugs are agents that inhibit the enzyme acetylcholinesterase, thereby increasing the availability and action of acetylcholine at cholinergic synapses. Here’s an analysis of the provided options:

1. **a. Pyridostigmine bromide**: **True.** Pyridostigmine is a reversible anticholinesterase drug used primarily in the treatment of myasthenia gravis.

2. **b. Edrophonium chloride**: **True.** Edrophonium is a reversible anticholinesterase and is often used in the diagnosis of myasthenia gravis.

3. **c. Carbachol**: **False.** Carbachol is a cholinergic agonist that acts directly on muscarinic and nicotinic receptors but is not classified as an anticholinesterase.

4. **d. Donepezil**: **True.** Donepezil is a reversible anticholinesterase drug used in the treatment of Alzheimer’s disease.

5. **e. Aceclidine**: **False.** Aceclidine is a direct-acting cholinergic agonist and is not an anticholinesterase drug.

6. **f. Armin**: **True.** Armin (an organophosphate) is an irreversible anticholinesterase drug.

7. **g. Neostigmine**: **True.** Neostigmine is a reversible anticholinesterase used for myasthenia gravis and to reverse the effects of certain neuromuscular blockers.

Based on this analysis, the correct answers for anticholinesterase drugs are: **a, b, d, f, and g.**

Select selective N-cholinomimetics

Question 24Select one or more:

a.
Aceclidine


b.
Pilocarpine


c.
Bethanechol


d.
Cytisine


e.
Nicotine

Selective N-cholinomimetics specifically target nicotinic acetylcholine receptors, which are found in the nervous system, autonomic ganglia, and at the neuromuscular junction. Here’s an analysis of the provided options regarding selective N-cholinomimetics:

1. **a. Aceclidine**: **False.** Aceclidine is a muscarinic agonist and primarily acts on muscarinic receptors, not nicotinic receptors.

2. **b. Pilocarpine**: **False.** Pilocarpine is also a muscarinic agonist and is used to treat glaucoma and dry mouth, and it does not selectively activate nicotinic receptors.

3. **c. Bethanechol**: **False.** Bethanechol is a muscarinic agonist that primarily stimulates muscarinic receptors, particularly in the bladder, and is not selective for nicotinic receptors.

4. **d. Cytisine**: **True.** Cytisine is a selective agonist for nicotinic receptors and is often used in smoking cessation therapies.

5. **e. Nicotine**: **True.** Nicotine is a selective N-cholinomimetic that targets nicotinic receptors in the nervous system and is commonly associated with tobacco products.

Based on this analysis, the correct selective N-cholinomimetics are: **d and e.**

Select selective М-cholinomimetics:

Question 25Select one or more:

a.
Pilocarpine


b.
Bethanechol


c.
Acetylcholine chloride


d.
Aceclidine


e.
Pyridostigmine bromide


f.
Carbachol


g.
Neostigmine

Selective M-cholinomimetics target muscarinic acetylcholine receptors and are used to mimic the effects of acetylcholine in various therapeutic contexts. Here’s an analysis of the provided options regarding selective M-cholinomimetics:

1. **a. Pilocarpine**: **True.** Pilocarpine is a selective muscarinic agonist used primarily in the treatment of glaucoma and xerostomia (dry mouth).

2. **b. Bethanechol**: **True.** Bethanechol is a selective muscarinic agonist that is often used to treat urinary retention and promote gastrointestinal motility.

3. **c. Acetylcholine chloride**: **False.** Acetylcholine is a non-selective agonist that acts on both muscarinic and nicotinic receptors and is not considered a selective M-cholinomimetic.

4. **d. Aceclidine**: **True.** Aceclidine is a muscarinic agonist used to treat glaucoma and is selective for muscarinic receptors.

5. **e. Pyridostigmine bromide**: **False.** Pyridostigmine is an anticholinesterase that increases acetylcholine levels but does not directly act only as an M-cholinomimetic.

6. **f. Carbachol**: **False.** Carbachol acts on both muscarinic and nicotinic receptors, making it non-selective.

7. **g. Neostigmine**: **False.** Neostigmine is also an anticholinesterase that increases acetylcholine availability but does not selectively mimic muscarinic receptor activity.

Based on this analysis, the correct selective M-cholinomimetics are: **a, b, and d.**